IP and R&D Spark Newsletter

This month’s Legal Watch captures a pivotal end-of-year reset for patent strategy. The USPTO’s new AI guidelines reshape how innovators frame enablement, inventorship, and disclosure, while November PTAB/USPTO developments signal deeper structural shifts in post-grant practice. On the litigation front, a California jury awards $634M against Apple in the Masimo dispute, and a Texas jury orders $191.4M against Samsung in a display patent case—two verdicts that close 2025 with decisive enforcement momentum.

In Industry News, the USPTO extends the comment period for the proposed “One Challenge” PTAB rulemaking, and joins the EPO and JPO in a trilateral AI working group, aligning tools and policy on AI examination. The EPO updates public file-inspection rules (effective Jan 1, 2026), while the JPO highlights progress across TM5 & IP5 on trademark cooperation, PPH, and AI adoption in examination. WIPO’s initiatives expand alternative dispute resolution with a “Mediation Pledge” for SEP holders supporting IoT SMEs.

This month’s Techno Spotlight spans frontier science to scaled deployment.

• Chemicals & Materials: Scientists unveil seven high-entropy oxide ceramics, identify cancer-linked chemicals in common foods, demonstrate an artificial CO₂-to-product “leaf”, and reveal a gold-powered green catalyst that breaks a decade-old benchmark.
• Life Sciences: Advances range from injectable brain implants for noninvasive neuromodulation and AI dentistry (DentoSMART-LDM) to CellXpress.AI for autonomous biomedical research and AI-driven neuro-rehab closing the BCI loop.
• Hi-Tech: MediaTek × NVIDIA collaborate on the GB10 Grace Blackwell superchip for DGX Spark, while a breakthrough quantum algorithm and 50-qubit simulation (Jülich) push the physics frontier; IBM × Cisco team up toward a quantum internet.
• Consumer Goods: Kimberly-Clark to acquire Kenvue, creating a $32B health & wellness leader; PepsiCo/Griffith/Milhão launch a regenerative ag pilot; Probi expands into sports & pet care; Melts files for an oral strip breakthrough.
• Chemical Safety & Regulatory Affairs: Debates rise over uranium in breast milk; BASF plans a full PFAS phase-out by 2028; the FDA clears reformulated ranitidine and the first SC therapy for high-risk smoldering myeloma; ISO 10993-1:2025 tightens biocompatibility-risk links; ECHA delays an ethanol disinfectant decision and proposes four new SVHCs; AICIS signals a 2026 reset to high-hazard rules; the FDA launches a real-time cosmetics AER dashboard.
• Automobile, e-mobility & Mechanical: Audi touts a V-6 diesel with zero turbo lag; GM reorganizes software leadership; PHEVs surpass diesel sales in Europe for the first time; Nissan & Mercedes close their joint factory.
• Standard Essential Patents: Ericsson launches a global SEP suit vs Transsion; China completes Phase-1 nationwide 6G trials; HP Inc. joins the Sisvel Wi-Fi 6 pool, ending disputes with multiple parties; SoftBank’s 7 GHz trial emerges as a strong 6G candidate band.

Stay tuned for more innovation shaping the IP and R&D landscape!